Capstone Asset Management’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q2 | $4.18M | Sell |
77,558
-4,576
| -6% | -$247K | 0.12% | 212 |
|
|
2017
Q1 | $4.33M | Buy |
82,134
+5,136
| +7% | +$271K | 0.12% | 199 |
|
|
2016
Q4 | $3.71M | Buy |
76,998
+1,032
| +1% | +$49.7K | 0.11% | 227 |
|
|
2016
Q3 | $4.1M | Buy |
75,966
+496
| +0.7% | +$26.7K | 0.12% | 200 |
|
|
2016
Q2 | $4.09M | Buy |
75,470
+3,008
| +4% | +$163K | 0.12% | 190 |
|
|
2016
Q1 | $3.67M | Sell |
72,462
-2,384
| -3% | -$121K | 0.11% | 249 |
|
|
2015
Q4 | $3.78M | Buy |
74,846
+5,080
| +7% | +$256K | 0.11% | 232 |
|
|
2015
Q3 | $3.35M | Buy |
69,766
+2,735
| +4% | +$131K | 0.1% | 250 |
|
|
2015
Q2 | $3.49M | Sell |
67,031
-320
| -0.5% | -$16.7K | 0.1% | 253 |
|
|
2015
Q1 | $3.89M | Sell |
67,351
-5,352
| -7% | -$309K | 0.11% | 229 |
|
|
2014
Q4 | $3.88M | Buy |
72,703
+11,245
| +18% | +$601K | 0.11% | 231 |
|
|
2014
Q3 | $3.53M | Sell |
61,458
-734
| -1% | -$42.2K | 0.12% | 208 |
|
|
2014
Q2 | $4.16M | Buy |
62,192
+1,441
| +2% | +$96.3K | 0.13% | 183 |
|
|
2014
Q1 | $4.06M | Buy |
60,751
+1,365
| +2% | +$91.2K | 0.12% | 195 |
|
|
2013
Q4 | $3.96M | Buy |
59,386
+5,557
| +10% | +$371K | 0.12% | 209 |
|
|
2013
Q3 | $3.38M | Buy |
53,829
+16,759
| +45% | +$1.05M | 0.08% | 278 |
|
|
2013
Q2 | $2.32M | Buy |
+37,070
| New | +$2.32M | 0.06% | 363 |
|